At its virtual capital markets day on 9 September, Merck KGaA announced that it aims to increase group sales by 6%/year to about €25 billion/year by 2025. To this end, investment, which will increase by 50% in the years 2021-2025 compared to 2016-2020.
Following a digital pitch day and evaluation by an internal panel, Heraeus has launched its third ‘accelerator programme with five start-ups, who will have access to its research laboratories, test equipment and customer and partner network.
Mitsui Chemicals Agro, the agrochemicals subsidiary of Mitsui Chemicals, has agreed to acquire the agrochemicals business of its Japanese compatriot Meiji Seika Pharma. No financial details were disclosed, other than that the impact on total sales is expected to be minor.
In speciality chemicals, doing your MA&D ‘homework’ means much more than it used to, says Lauren McCallum, solution manager for SAP’s Chemical Industry business unit
According to unconfirmed reports, private equity firm Permira is considering exiting from its ownership in CABB after seven years and an auction may begin next year. The German-headquarters fine and speciality chemicals producer could raise about $1.2 billion, it is estimated.
The UK’s Chemical Business Association (CBA) has written to various government ministers, warning that “the supply chain situation in the UK is deteriorating” because of the continuing and deepening shortage of HGV drivers.
CDMO Sterling Pharma Solutions has completed the initial phase of investment in its centre of excellence for research into the commercial applications of continuous flow chemistry at Dudley, UK.
Two companies active in the speciality chemicals sector - chemicals distributor Azelis and Nouryon, the former chemicals division of AkzoNobel – have separately announced IPOs in recent weeks. Both are currently owned by private equity.
Quotient Sciences is to invest £6.3 million to expand drug substance manufacturing at the site in Alnwick, UK, which it acquired along with Arcinova in February. This will also create 80 new jobs over the next three years and boost its capacity to develop complex medicines tenfold.
Current Issue
At its virtual capital markets day on 9 September, Merck KGaA announced that it aims to increase group sale
Following a digital pitch day and evaluation by an internal panel, Heraeus has launched its third ‘accelera
Mitsui Chemicals Agro, the agrochemicals subsidiary of Mitsui Chemicals, has agreed to acquire the agrochem
In speciality chemicals, doing your MA&D ‘homework’ means much more than it used to, says L
Most Popular
The European Chemicals Agency (ECHA) and the European Commission have announced plans to help EU member states and industry to address disinfectant shortages caused by the Covid-19 pandemic.
In a pre-close trading update for the financial year ended 31 March 2021, Johnson Matthey (JM) CEO Robert MacLeod revealed that: “We have commenced a strategic review of Health, as we continue to focus resources to maximise value for our shareholders”.
Full results will be announced on 27 May but it is known that Health, which offers API custom manufacturing services, controlled substances, catalysts and generics, generated sales of £223 million, about 5% of the total sale. The division’s full-year operating performance is expected to be above the prior year.
Roger-Marc Nicoud, CEO of Ypso-Facto, looks at the challenges and opportunities for CDMOs in the current crisis*
The current crisis has highlighted the dependence of European and, indeed, North American countries on delocalised production. This is the case for many goods, including APIs and drugs in general.
